| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 74.45M | 74.45M | 104.39M | 87.69M | 86.94M | 168.16M |
| Gross Profit | 8.26M | 8.26M | -27.30M | 2.55M | 11.13M | 18.92M |
| EBITDA | -7.79M | -211.66M | -108.34M | -31.67M | -10.72M | 23.07M |
| Net Income | -281.36M | -281.36M | -173.89M | -189.33M | -34.87M | 4.50M |
Balance Sheet | ||||||
| Total Assets | 813.40M | 813.40M | 1.15B | 1.36B | 1.59B | 1.55B |
| Cash, Cash Equivalents and Short-Term Investments | 63.60M | 63.60M | 100.90M | 167.49M | 110.14M | 369.79M |
| Total Debt | 170.28M | 170.28M | 279.64M | 312.80M | 331.59M | 240.99M |
| Total Liabilities | 256.61M | 256.61M | 296.13M | 328.20M | 359.28M | 269.87M |
| Stockholders Equity | 579.49M | 579.49M | 861.37M | 1.04B | 1.23B | 1.28B |
Cash Flow | ||||||
| Free Cash Flow | 19.38M | 14.54M | -158.00K | -93.72M | -14.55M | 121.50M |
| Operating Cash Flow | 20.59M | 15.75M | 678.00K | -93.68M | -14.47M | 121.60M |
| Investing Cash Flow | 290.00K | 5.44M | -27.99M | 112.76M | -325.28M | 264.86M |
| Financing Cash Flow | -58.20M | -58.20M | -38.05M | 42.01M | 79.25M | -265.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
45 Neutral | HK$92.87M | -0.29 | -32.62% | ― | 3574.59% | 48.95% | |
45 Neutral | HK$120.49M | -1.25 | -24.60% | ― | -72.39% | 26.33% | |
44 Neutral | HK$60.07M | -0.26 | -31.70% | ― | -70.09% | -16.86% | |
38 Underperform | HK$93.29M | -0.48 | -37.65% | ― | -54.13% | 24.72% |
Rykadan Capital Limited reported its unaudited interim results for the six-month period ending September 30, 2025, revealing a loss of HK$25.1 million from both continuing and discontinued operations, a notable improvement from the HK$91.1 million loss in the same period the previous year. Despite a decrease in revenue from continuing operations, the company saw a profit from discontinued operations, but the board decided not to recommend an interim dividend, reflecting cautious financial management amid challenging market conditions.
The most recent analyst rating on (HK:2288) stock is a Hold with a HK$0.14 price target. To see the full list of analyst forecasts on Rykadan Capital Ltd. stock, see the HK:2288 Stock Forecast page.
Rykadan Capital Ltd. has announced a board meeting scheduled for November 26, 2025, to discuss and approve the unaudited consolidated financial statements for the six months ending September 30, 2025. The meeting will also consider the payment of an interim dividend and the publication of the interim results, potentially impacting the company’s financial transparency and shareholder returns.